I. Emery

Secondary Echinococcus multilocularis infection in A/J mice: delayed metacestode development is associated with Th1 cytokine production

C. Leclerc, M. Liance, I. Emery, 1997, Parasite immunology.

Echinococcus multilocularis infection in mice: in vivo treatment with a low dose of IFN-gamma decreases metacestode growth and liver fibrogenesis.

S. Ricard-Blum, D. Vuitton, R. Houin, 1998, Parasite.

In vivo treatment with recombinant IL‐12 protects C57BL/6J mice against secondary alveolar echinococcosis

C. Leclerc, D. Vuitton, M. Liance, 1998, Parasite immunology.

Characterization of T‐cell immune responses of Echinococcus multilocularis‐infected C57BL/6J mice

C. Leclerc, E. Dériaud, D. Vuitton, 1996, Parasite immunology.

In vitro quantitative assessment of Echinococcus multilocularis metacestode viability after in vivo and in vitro maintenance.

C. Bories, R. Houin, M. Liance, 1995, International journal for parasitology.

Specific cellular and humoral immune responses induced by different antigen preparations of Echinococcus multilocularis metacestodes in patients with alveolar echinococcosis.

H. Auer, D. Vuitton, S. Bresson‐Hadni, 1994, Parasite.

Lack of H-2 gene influence on mouse susceptibility to secondary alveolar echinococcosis.

C. Leclerc, D. Vuitton, R. Houin, 1997, International journal for parasitology.

Development of an injectable formulation of albendazole and in vivo evaluation of its efficacy against Echinococcus multilocularis metacestode.

H. Fessi, C. Bories, J. Devissaguet, 1995, International journal for parasitology.